About deepCDR Biologics
deepCDR Biologics is a Healthcare company based in Basel (Switzerland) founded in 2019 by Sai Reddy, and was acquired by Alloy Therapeutics in December 2021. Diagnostic and pharmaceutical products are manufactured by deepCDR Biologics. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Discovery.
Company details
deepCDR Biologics was founded in 2019 in Basel, Switzerland, with Sai Reddy serving as co-founder. Diagnostic and pharmaceutical products are developed and produced by the company within the biologics sector. Operations are centered on healthcare applications, including testing and treatment solutions. The focus remains on manufacturing processes tailored to medical needs, supported by a presence in the European pharmaceutical landscape.
- Headquarters Basel, Switzerland
- Founders Sai Reddy
- Stage Acquired
- SectorsHealthcare
- Website deepcdr.com
- Acquired by Alloy Therapeutics (Dec 2021)
- Investors
- Acquired byAlloy Therapeutics
(Dec 2021)
Investors in deepCDR Biologics
deepCDR Biologics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Alloy Therapeutics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Drug discovery services are provided for therapeutic development. | 2017 | alloytx.com | Lexington, United States |
Investor details for deepCDR Biologics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of deepCDR Biologics
1 people are tracked at deepCDR Biologics (1 in leadership).
| Name | Role | Group |
|---|---|---|
Sai Reddy | Co-Founder | Leadership |
Complete people profiles for deepCDR Biologics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of deepCDR Biologics
2 dated milestones of deepCDR Biologics across 2 years, from founding to its latest funding, stage changes and deals.
- Founded deepCDR Biologics is founded.
- Exit Acquired by Alloy Therapeutics.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Deepcdr Biologics
Complete news archive for deepCDR Biologics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about deepCDR Biologics
deepCDR Biologics was founded in 2019.
deepCDR Biologics is headquartered in Basel, Switzerland. It is registered at Basel, Basel-stadt, Switzerland.
deepCDR Biologics was founded in 2019 in Basel, Switzerland, with Sai Reddy serving as co-founder. Diagnostic and pharmaceutical products are developed and produced by the company within the biologics sector. Operations are centered on healthcare applications, including testing and treatment solutions. The focus remains on manufacturing processes tailored to medical needs, supported by a presence in the European pharmaceutical landscape.
deepCDR Biologics has 1 investor. Key investors include Alloy Therapeutics.
Yes. deepCDR Biologics was acquired by Alloy Therapeutics in December 2021.